teduglutide Powder and solvent for solution for injection 1.25 mg, 5 mg
Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Denmark
, Finland
, Norway
, Sweden
, United Kingdom
, Finland
, Norway
, Sweden
, United Kingdom
Comments
Not available: EU, USA, Australia, Canada, MENA, GCC
Manufacturer #6301
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, MENA, LATAM, and NA for 20+ years.
Main therapeutic area include oncology and urology.
The company's production lines are GMP-compliant.
The main dosage forms includes injectable.
The company possesses subsidiaries in LATAM
Manufacturer usually replies in 17 days
None